Clinical Trials for Solid Tumor

Find clinical trials for solid tumor. Discover research opportunities and treatment options in your area.

343 Active Trials Found

Showing 343 trials on this page

Page 1 of 18

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT ID: NCT05735080

This clinical trial is studying a new oral medication called INX-315, which is being developed to treat advanced cancers, specifically hormone receptor-positive breast cancer and certain types of o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +12 more

Imaging of Solid Tumors Using 18F-TRX

NCT ID: NCT06942104

This clinical trial is studying a new imaging agent called 18F-TRX to see how safe and effective it is for detecting tumors in patients with solid cancers. 18F-TRX is a special tracer used during P...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States, San Francisco, California, United States

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

NCT ID: NCT06105021

This clinical trial is studying a new treatment called AFNT-211 for patients with advanced solid tumors that have a specific genetic change known as the KRAS G12V mutation. This mutation is commonl...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Nashville, Tennessee, United States +10 more

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

NCT ID: NCT06171750

This clinical trial is studying a new treatment called ANK-101 for patients with advanced solid tumors, which are cancers that form lumps or masses in different parts of the body. The trial is in i...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Bethesda, Maryland, United States +3 more

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

NCT ID: NCT04503278

This clinical trial is looking at a new treatment approach for patients with advanced solid tumors that express a specific protein called CLDN6. The study is testing an experimental therapy called ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Melbourne, Victoria, Australia, Heidelberg, , Germany +11 more

68Ga-MY6349 PET/CT in Solid Tumors

NCT ID: NCT07046702

This clinical trial is studying a new scanning method called 68Ga-MY6349 PET/CT to help detect a specific protein called Trop-2 on tumor cells in people with solid tumors (a type of cancer that for...

Recruiting

Type: observational Locations: Xiamen, Fujian, China

PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors

NCT ID: NCT06383598

This clinical trial is studying a new imaging technique called 68Ga-Nb-1 PET/CT, which aims to detect a specific protein, PD-L1, on tumors in patients with solid tumors. By identifying whether PD-L...

Recruiting

Phase: NA Type: interventional Locations: Beijing, , China, Beijing, Beijing, China

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT ID: NCT05981703

This clinical trial is looking at a new treatment called BGB-26808, both on its own and combined with another drug called tislelizumab, for people with advanced solid tumors. A solid tumor is a mas...

Recruiting

Phase: PHASE1 Type: interventional Locations: Miami, Florida, United States, Portland, Oregon, United States +29 more

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05919264

This clinical trial, called FOG-001, is investigating a new treatment for people with advanced or metastatic solid tumors, which are types of cancer that have spread beyond their original site. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +9 more

Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells

NCT ID: NCT07071909

This clinical trial is studying how well the immune system recovers after a special cancer treatment called CAR-T cell therapy, which is used to fight certain blood cancers and tumors. The study wi...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

NCT ID: NCT06975293

This clinical trial is studying the safety and effectiveness of a new treatment called STC-15 when combined with toripalimab for patients with certain advanced cancers, including lung cancer, melan...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Lake Success, New York, United States +2 more

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors

NCT ID: NCT05627063

This clinical trial is investigating a new treatment called ABSK121-NX for patients with advanced solid tumors, which are abnormal growths that can occur in various parts of the body, such as the l...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, La Jolla, California, United States +23 more

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

NCT ID: NCT03739827

This clinical trial is studying rare solid tumors, which are types of cancer that occur in less than 15 out of every 100,000 people each year. Researchers want to learn more about how these tumors ...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Houston, Texas, United States +2 more

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

NCT ID: NCT05103631

This clinical trial is studying a new treatment for certain types of solid tumors, specifically those that test positive for a protein called GPC3, which is often found in liver cancer and other ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

NCT ID: NCT06810544

This clinical trial is looking at a new treatment called TNG456, which is being tested alone and together with another medication called abemaciclib for patients with advanced solid tumors that hav...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Columbus, Ohio, United States +3 more

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

NCT ID: NCT07069062

This clinical trial is studying a new medicine called HY0001a to see if it is safe and effective for adults with advanced solid tumors—these are cancers that have spread and cannot be treated succe...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Implementation of an Oral Chemotherapy Adherence Intervention

NCT ID: NCT06989489

This clinical trial is studying a new program designed to help patients better stick to their oral cancer medications. The goal is to see how effective this program is in improving medication adher...

Recruiting

Phase: NA Type: interventional Locations: Chapel Hill, North Carolina, United States

Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT ID: NCT06895031

This clinical trial is testing a new drug called JYP0015 for patients with advanced solid tumors that have specific mutations in a gene called RAS. These tumors can include types of cancer like pan...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

NCT ID: NCT05584670

This clinical trial is looking at a new treatment called SAR445877 for adults with advanced solid tumors, which are cancers that cannot be surgically removed or have spread to other parts of the bo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hackensack, New Jersey, United States, Houston, Texas, United States +29 more

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

NCT ID: NCT02332668

This clinical trial is investigating a medication called pembrolizumab, which helps the immune system fight certain types of cancers in children, including melanoma (a type of skin cancer), solid t...

Recruiting

Phase: PHASE1 Type: interventional Locations: North Ryde, , Australia, Rome, , Italy +25 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions